Elanco Animal Health (ELAN) reported Q1 adjusted earnings Wednesday of $0.37 per diluted share, up from $0.34 a year earlier. Analysts polled by FactSet expected $0.31.
Revenue for the quarter ended March 31 was $1.19 billion compared with $1.21 billion a year earlier. Analysts expected $1.17 billion.
Shares of the company rose 3.5% in recent premarket activity as Elanco increased its annual revenue guidance to a range of $4.51 billion to $4.58 billion from the prior view of $4.45 billion to $4.51 billion. Analysts polled by FactSet expect $4.48 billion. The company held its 2025 adjusted earnings guidance of $0.80 to $0.86 per share.
For Q2, the company expects adjusted EPS of $0.17 to $0.21 and revenue of $1.18 billion to $1.20 billion. Analysts surveyed by FactSet expect adjusted earnings of $0.25 per share on revenue of $1.17 billion.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。